The US Food and Drug Administration has made available a development template with recommendations to streamline emergency use authorizations of screening tests for serial COVID-19 testing, which developers can consider before conducting certain performance evaluations with asymptomatic patients.
If the recommendations are followed, the FDA may grant an EUA for OTC distribution to certain point-of-care or at-home tests...